- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Pfizer Limited has announced a board meeting outcome, approving a Marketing and Supply Agreement with Mylan Pharmaceuticals for the marketing and sale of its brands Ativan and Pacitane. The agreement spans five years and focuses on domestic operations in India. This collaboration aims to leverage Mylan's expertise in Central Nervous System therapies to enhance product distribution and in-clinic presence, which could positively impact Pfizer's market reach and sales performance.